Early real-world data suggest promising results in post-bariatric patients, though formal trials are limited
More encouraging research in mice indicates that MK677 administration over a lifetime can reduce amyloid beta buildup and that this does, in fact, decrease neuron and synapse loss
For years, John Ang tried to tell people what he'd found, how huge this could be for diabetes, but he couldn't get anyone to pay attention
Under the short-term program, called the Medicare GLP-1 Bridge, Medicare will cover GLP-1s approved for weight reduction Wegovy and Zepbound for eligible beneficiaries enrolled in Medicare Part D for a $50 copayment
In addition, they're non-GMO verified, vegan-friendly, gluten-free and naturally colored from organic maqui berries